Sequoia Financial Advisors LLC grew its position in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 19.0% in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 14,866 shares of the semiconductor company’s stock after acquiring an additional 2,377 shares during the quarter. Sequoia Financial Advisors LLC’s holdings in Synopsys were worth $6,631,000 at the end of the most recent reporting period.
A number of other large investors also recently modified their holdings of SNPS. AGH Wealth Advisors LLC grew its stake in Synopsys by 4.4% in the first quarter. AGH Wealth Advisors LLC now owns 569 shares of the semiconductor company’s stock valued at $226,000 after purchasing an additional 24 shares in the last quarter. Hardy Reed LLC grew its position in shares of Synopsys by 0.8% in the fourth quarter. Hardy Reed LLC now owns 3,309 shares of the semiconductor company’s stock valued at $1,554,000 after purchasing an additional 25 shares during the last quarter. Annis Gardner Whiting Capital Advisors LLC increased its position in Synopsys by 16.9% during the 4th quarter. Annis Gardner Whiting Capital Advisors LLC now owns 180 shares of the semiconductor company’s stock worth $85,000 after buying an additional 26 shares during the period. MCF Advisors LLC grew its stake in shares of Synopsys by 17.8% in the fourth quarter. MCF Advisors LLC now owns 172 shares of the semiconductor company’s stock valued at $81,000 after acquiring an additional 26 shares in the last quarter. Finally, CYBER HORNET ETFs LLC increased its holdings in shares of Synopsys by 5.5% during the fourth quarter. CYBER HORNET ETFs LLC now owns 522 shares of the semiconductor company’s stock worth $245,000 after purchasing an additional 27 shares during the period. 85.47% of the stock is currently owned by institutional investors and hedge funds.
Synopsys Stock Up 0.1%
Synopsys stock opened at $397.38 on Friday. The firm has a market capitalization of $76.15 billion, a price-to-earnings ratio of 70.21, a price-to-earnings-growth ratio of 2.18 and a beta of 1.23. The company has a current ratio of 1.34, a quick ratio of 1.24 and a debt-to-equity ratio of 0.29. Synopsys, Inc. has a 1-year low of $366.00 and a 1-year high of $539.48. The firm’s fifty day moving average price is $407.30 and its two-hundred day moving average price is $438.00.
Analyst Upgrades and Downgrades
SNPS has been the topic of a number of recent analyst reports. Morgan Stanley decreased their price target on Synopsys from $525.00 to $500.00 and set an “equal weight” rating on the stock in a research report on Wednesday, August 19th. Weiss Ratings upgraded Synopsys from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, August 27th. UBS Group set a $570.00 target price on Synopsys in a research report on Thursday, August 27th. BNP Paribas Exane lifted their price objective on Synopsys from $425.00 to $450.00 and gave the stock an “underperform” rating in a research note on Thursday, May 28th. Finally, Berenberg Bank set a $633.00 price target on shares of Synopsys in a research report on Wednesday, May 27th. Thirteen analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $562.67.
Get Our Latest Analysis on SNPS
Insider Activity
In other Synopsys news, insider Aart de Geus sold 25,000 shares of the company’s stock in a transaction dated Monday, August 31st. The shares were sold at an average price of $441.76, for a total value of $11,044,000.00. Following the completion of the sale, the insider directly owned 120,421 shares of the company’s stock, valued at approximately $53,197,180.96. This represents a 17.19% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,603 shares of the company’s stock in a transaction that occurred on Monday, June 15th. The shares were sold at an average price of $458.96, for a total value of $6,702,192.88. Following the completion of the transaction, the chief executive officer directly owned 75,020 shares of the company’s stock, valued at approximately $34,431,179.20. This represents a 16.29% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last 90 days, insiders have sold 89,244 shares of company stock worth $39,220,364. 0.56% of the stock is owned by corporate insiders.
Synopsys Profile
Synopsys, Inc is a technology company that develops electronic design automation (EDA) software, semiconductor intellectual property (IP), and related services. Its products help semiconductor and electronics companies design, verify, test and manufacture integrated circuits and complex electronic systems.
The company’s EDA portfolio includes tools for digital and analog design, simulation, verification, physical implementation, signoff and manufacturing preparation. Synopsys also provides reusable semiconductor IP, including processor cores, interface technologies, embedded memories and security-related components, which customers can incorporate into system-on-chip designs.
Synopsys additionally offers software integrity and application security solutions that help organizations identify and manage vulnerabilities and risks in the software development lifecycle.
See Also
- Five stocks we like better than Synopsys
- Block Makes a Federal Trust Bank Move That Could Reshape Its Fintech Model
- Kroger’s Textbook Entry for Buy-and-Hold Investors
- AST SpaceMobile Looks to Extend Its 30-Day FCC Satellite Testing Window
- Amgen Drops 10% on a Trial It Didn’t Even Run
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
